Supplements
Malaria
In this supplement
The world is on the verge of making major inroads against malaria — a deadly disease that still claims the lives of more than 1 million people annually, mostly children less than 5 years of age. Over the past decade, scientists, large pharmaceutical companies and small biotechnology firms, governments and philanthropic organizations have come together to mount a full frontal attack on malaria, and there is now even talk of the 'E word' — that is, eradication. This collection highlights advances in the deployment of existing tools, and in the basic science of malaria — particularly those flowing from sequencing of the malaria parasite genomes — that will underpin the next generation of malaria-control tools, which will be needed if the scourge of malaria is to be eradicated.
Top of page
Editorial
Editorial
On the verge
Declan Butler and Claudia Lupp
Top of page
News and Opinion
News Feature
Malaria: The end of the beginning
After decades of work, a pioneering malaria vaccine may soon reach the final phase of clinical trials. In the first of two features on efforts against malaria, Brendan Maher reports on a vaccine that is far from perfect — but which may provide new direction and save thousands of lives.
Brendan Maher
Naturenews 451, 1042—1046 (2008)
doi:10.1038/4511042a
News
Malaria vaccine gets shot in the arm from tests
Promising results pave the way for a vaccine candidate to undergo full-blown trials across Africa.
Brendan Maher
Naturenews 456, 680—681 (2008)
doi:10.1038/456680a
News Feature
Malaria: The big push
Zambia, with help from partners around the world, is stepping up its battle against malaria. Michael Hopkin reports from the rural front line.
Michael Hopkin
Naturenews 451, 1047—1049 (2008)
doi:10.1038/4511047a
Commentary
The billion-dollar malaria moment
For years the global malaria effort has been asking for more resources. Now the field needs to figure out a systematic strategy for spending the money effectively, says Mark Grabowsky.
Mark Grabowsky
Nature 451, 1051—1052 (28 February 2008)
doi:10.1038/4511051a
Top of page
Research
Review
Malaria research in the post-genomic era
Elizabeth A. Winzele
Nature 455, 751—756 (9 October 2008) doi:10.1038/nature07361
Article
Comparative genomics of the neglected human malaria parasite Plasmodium vivax
Jane M. Carlton et al.
Nature 455, 757—763 (9 October 2008) doi:10.1038/nature07327
Article
Genome sequence of the human malaria parasite Plasmodium falciparum
Malcolm J. Gardner et al.
Nature 419, 498—511 (3 October 2002) doi:10.1038/nature01097
Article
Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii
Jane M. Carlton et al.
Nature 419, 512—519 (3 October 2002) doi:10.1038/nature01099
Letter
The genome of the simian and human malaria parasite Plasmodium knowlesi
A. Pain et al.
Nature 455, 799—803 (9 October 2008) doi:10.1038/nature07306
Top of page
Links
- Nature Web Focus Malaria
- Improved Diagnostics for the Developing World
- Nature Specials Malaria
- Nature Outlook: Malaria
- Nature Insight Malaria
- Nature Focus on malaria
- Nature Medicine focus on malaria




